Matthew Pine
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune responses and vaccinations
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Immunotherapy and Immune Responses 3
-
- Influenza Virus Research Studies 2
- Respiratory viral infections research 1
- Co-authors
- Norbert Pardi (3 shared papers)Ying K. Tam (3 shared papers)Drew Weissman (2 shared papers)Raffael Nachbagauer (2 shared papers)Alec W. Freyn (2 shared papers)Victoria C. Rosado (2 shared papers)Florian Krammer (2 shared papers)Peter Palese (2 shared papers)
- Journals
- Molecular Therapy (2 papers)Immunity (2 papers)Molecular Therapy — Methods & Clinical Development (1 paper)Vaccine (1 paper)Journal of Biomedical Materials Research Part B Applied Biomaterials (1 paper)
- Partner nations
- United StatesBrazilThailand
In The Last Decade
Matthew Pine
7 papers receiving 985 citations
Matthew Pine's Hit Papers
Peers
Comparison fields: 5 of 64
- Immunology 276
- Infectious Diseases 219
- Molecular Biology 383
- Virology 23
- Epidemiology 154
Countries citing papers authored by Matthew Pine
This map shows the geographic impact of Matthew Pine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Pine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Pine more than expected).
Fields of papers citing papers by Matthew Pine
This network shows the impact of papers produced by Matthew Pine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Pine. The network helps show where Matthew Pine may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew Pine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses Hit paper breakdown → | 2021 | 592 |
| 2 | A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice Hit paper breakdown → | 2020 | 252 |
| 3 | 2023 | 61 | |
| 4 | 2022 | 55 | |
| 5 | 2021 | 32 | |
| 6 | 2018 | 19 | |
| 7 | 2018 | 11 |
About Matthew Pine
Matthew Pine is a scholar working on Immunology, Epidemiology, Parasitology, Urology and Molecular Biology, having authored 7 papers that have together received 1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (3 papers), Influenza Virus Research Studies (2 papers), RNA Interference and Gene Delivery (2 papers), Periodontal Regeneration and Treatments (1 paper), Vector-borne infectious diseases (1 paper), Tissue Engineering and Regenerative Medicine (1 paper) and Respiratory viral infections research (1 paper). The work is most often cited by research in Immunology (276 citations), Infectious Diseases (219 citations), Molecular Biology (383 citations), Virology (23 citations) and Epidemiology (154 citations). Matthew Pine has collaborated with scholars based in United States, Brazil and Thailand. Frequent co-authors include Norbert Pardi, Ying K. Tam, Drew Weissman, Raffael Nachbagauer, Alec W. Freyn, Victoria C. Rosado, Florian Krammer, Peter Palese, Thomas D. Madden and Lynda Coughlan. Their work appears in journals such as Molecular Therapy, Immunity, Molecular Therapy — Methods & Clinical Development, Vaccine and Journal of Biomedical Materials Research Part B Applied Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.